Sandra L. Fenwick - 17 May 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Director
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol: TDOC
Transactions as of: 17 May 2021
Net transactions value: $0
Form type: 4
Filing time: 18 May 2021, 16:14:23 UTC
Next filing: 26 May 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Award	$0	+1,638		$0.000000	1,638	17 May 2021	Common Stock	1,638		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2	The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.

Content

Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.